secwatch / observer
8-K filed July 1, 2024, 7:59 PM ET ticker CARM CIK 0001485003
leadership confidence high sentiment neutral materiality 0.40

Carisma Therapeutics appoints Thorell and Scadden to board; Hodits and Odlander resign

Carisma Therapeutics Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Regina Hodits

Director
CARM · Carisma Therapeutics Inc.
Effective
2024-06-30
Filed
July 1, 2024, 7:59 PM ET
On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.
Departed

Björn Odlander

Director
CARM · Carisma Therapeutics Inc.
Effective
2024-06-30
Filed
July 1, 2024, 7:59 PM ET
On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.
Appointed

Marella Thorell

Director
CARM · Carisma Therapeutics Inc.
Effective
2024-06-30
Filed
July 1, 2024, 7:59 PM ET
On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.
Appointed

David Scadden

Director
CARM · Carisma Therapeutics Inc.
Effective
2024-06-30
Filed
July 1, 2024, 7:59 PM ET
On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Regina Hodits resigned as Director at Carisma Therapeutics Inc..

Action
resigned
Role
Director
Exact text from the filing
On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Björn Odlander resigned as Director at Carisma Therapeutics Inc..

Action
resigned
Role
Director
Exact text from the filing
On June 26, 2024, each of Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D. notified Carisma Therapeutics Inc. (the “Company”) of their respective decisions to resign from the Company’s board of directors, effective June 30, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Marella Thorell was elected as Director at Carisma Therapeutics Inc..

Action
elected
Role
Director
Exact text from the filing
On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

David Scadden was elected as Director at Carisma Therapeutics Inc..

Action
elected
Role
Director
Exact text from the filing
On June 26, 2024, the board of directors elected Marella Thorell and David Scadden, M.D. as directors of the Company, effective June 30, 2024.
View on SEC.gov

Carisma Therapeutics Inc. filing history →

Source: SEC EDGAR
accession 0001104659-24-076578
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.